Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

Bayer said on Wednesday it had cut about 12,000 full-time positions since the start of a restructuring programme to speed up ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...

Ordinarily, Bayer’s ownership of the Bayer Leverkusen football team does not factor much into its financial results. Read ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...